Now showing items 1-3 of 3

    • Calcineurin Inhibitor Minimization in the Symphony Study: Observational Results 3 Years after Transplantation 

      Ekberg, H.; Bernasconi, C.; Tedesco-Silva Junior, Hélio [UNIFESP]; Vitko, S.; Hugo, C.; Demirbas, A.; Reyes Acevedo, R.; Grinyo, J.; Frei, U.; Vanrenterghem, Y.; Daloze, P.; Halloran, P. F. (Wiley-Blackwell, 2009-08-01)
      The Symphony study showed that at 1 year posttransplant, a regimen based on daclizumab induction, 2 g mycophenolate mofetil (MMF), low-dose tacrolimus and steroids resulted in better renal function and lower acute rejection ...

    • Extended treatment with pegylated interferon alfa/ribavirin in patients with genotype 2/3 chronic hepatitis C who do not achieve a rapid virological response: final analysis of the randomised N-CORE trial 

      Shiffman, Mitchell L.; Cheinquer, Hugo; Berg, Christoph P.; Berg, Thomas; Figueiredo-Mendes, Claudio de; Dore, Gregory J.; Ferraz, Maria Lucia [UNIFESP]; Mendes-Correa, Maria Cassia; Lima, Maria Patelli; Parise, Edison R. [UNIFESP]; Perez Rios, Alma Minerva; Reuter, Tania; Sanyal, Arun J.; Shafran, Stephen D.; Hohmann, Marc; Tatsch, Fernando; Bakalos, George; Zeuzem, Stefan (Springer, 2014-10-01)
      Background and aims the combination of pegylated interferon alfa/ribavirin will likely remain the treatment of choice for HCV genotype 2/3 patients in financially constrained countries for the foreseeable future. Patients ...

    • Predictive value of FIB-4 and APRI versus METAVIR on sustained virologic response in genotype 1 hepatitis C patients 

      Ferenci, Peter; Aires, Rodrigo; Beavers, Kimberly L.; Curescu, Manuela; Abrao Ferreira, Paulo R. [UNIFESP]; Gschwantler, Michael; Ion, Stefan; Larrey, Dominique; Maticic, Mojca; Puoti, Massimo; Schuller, Janos; Tornai, Istvan; Tusnadi, Anna; Messinger, Diethelm; Tatsch, Fernando; Horban, Andrzej (Springer, 2014-01-01)
      Advanced liver fibrosis is a negative predictor of virologic response in genotype 1 chronic hepatitis C (CHC) patients. Biopsy, however, is invasive, costly, and carries some risk of complications.Using data from the ...